Skip to main content
NCBI home page
Gut logoLink to Gut
. 1997 Feb;40(2):284–285. doi: 10.1136/gut.40.2.284

Mesalazine as a maintenance treatment in Crohn's disease: is it the long awaited solution?

T Sahmoud 1, J Y Mary 1, T Sahmoud 1
PMCID: PMC1027063  PMID: 9071946

Full text

PDF
284

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bouhnik Y., Lémann M., Mary J. Y., Scemama G., Taï R., Matuchansky C., Modigliani R., Rambaud J. C. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Lancet. 1996 Jan 27;347(8996):215–219. doi: 10.1016/s0140-6736(96)90402-x. [DOI] [PubMed] [Google Scholar]
  2. Brignola C., Campieri M., Bazzocchi G., Farruggia P., Tragnone A., Lanfranchi G. A. A laboratory index for predicting relapse in asymptomatic patients with Crohn's disease. Gastroenterology. 1986 Dec;91(6):1490–1494. doi: 10.1016/0016-5085(86)90206-4. [DOI] [PubMed] [Google Scholar]
  3. Brignola C., Iannone P., Pasquali S., Campieri M., Gionchetti P., Belluzzi A., Basso O., Miglioli M., Barbara L. Placebo-controlled trial of oral 5-ASA in relapse prevention of Crohn's disease. Dig Dis Sci. 1992 Jan;37(1):29–32. doi: 10.1007/BF01308338. [DOI] [PubMed] [Google Scholar]
  4. Caprilli R., Andreoli A., Capurso L., Corrao G., D'Albasio G., Gioieni A., Assuero Lanfranchi G., Paladini I., Pallone F., Ponti V. Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC). Aliment Pharmacol Ther. 1994 Feb;8(1):35–43. doi: 10.1111/j.1365-2036.1994.tb00158.x. [DOI] [PubMed] [Google Scholar]
  5. Gendre J. P., Mary J. Y., Florent C., Modigliani R., Colombel J. F., Soulé J. C., Galmiche J. P., Lerebours E., Descos L., Viteau J. M. Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID) Gastroenterology. 1993 Feb;104(2):435–439. doi: 10.1016/0016-5085(93)90411-5. [DOI] [PubMed] [Google Scholar]
  6. Malchow H., Ewe K., Brandes J. W., Goebell H., Ehms H., Sommer H., Jesdinsky H. European Cooperative Crohn's Disease Study (ECCDS): results of drug treatment. Gastroenterology. 1984 Feb;86(2):249–266. [PubMed] [Google Scholar]
  7. Messori A., Brignola C., Trallori G., Rampazzo R., Bardazzi G., Belloli C., d'Albasio G., De Simone G., Martini N. Effectiveness of 5-aminosalicylic acid for maintaining remission in patients with Crohn's disease: a meta-analysis. Am J Gastroenterol. 1994 May;89(5):692–698. [PubMed] [Google Scholar]
  8. Modigliani R., Colombel J. F., Dupas J. L., Dapoigny M., Costil V., Veyrac M., Duclos B., Soulé J. C., Gendre J. P., Galmiche J. P. Mesalamine in Crohn's disease with steroid-induced remission: effect on steroid withdrawal and remission maintenance, Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. Gastroenterology. 1996 Mar;110(3):688–693. doi: 10.1053/gast.1996.v110.pm8608877. [DOI] [PubMed] [Google Scholar]
  9. O'Donoghue D. P., Dawson A. M., Powell-Tuck J., Bown R. L., Lennard-Jones J. E. Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease. Lancet. 1978 Nov 4;2(8097):955–957. doi: 10.1016/s0140-6736(78)92524-2. [DOI] [PubMed] [Google Scholar]
  11. Prantera C., Pallone F., Brunetti G., Cottone M., Miglioli M. Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's disease. The Italian IBD Study Group. Gastroenterology. 1992 Aug;103(2):363–368. doi: 10.1016/0016-5085(92)90822-g. [DOI] [PubMed] [Google Scholar]
  12. Sahmoud T., Hoctin-Boes G., Modigliani R., Bitoun A., Colombel J. F., Soule J. C., Florent C., Gendre J. P., Lerebours E., Sylvester R. Identifying patients with a high risk of relapse in quiescent Crohn's disease. The GETAID Group. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives. Gut. 1995 Dec;37(6):811–818. doi: 10.1136/gut.37.6.811. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Stewart L. A., Parmar M. K. Meta-analysis of the literature or of individual patient data: is there a difference? Lancet. 1993 Feb 13;341(8842):418–422. doi: 10.1016/0140-6736(93)93004-k. [DOI] [PubMed] [Google Scholar]
  14. Summers R. W., Switz D. M., Sessions J. T., Jr, Becktel J. M., Best W. R., Kern F., Jr, Singleton J. W. National Cooperative Crohn's Disease Study: results of drug treatment. Gastroenterology. 1979 Oct;77(4 Pt 2):847–869. [PubMed] [Google Scholar]
  15. Willoughby J. M., Beckett J., Kumar P. J., Dawson A. M. Controlled trial of azathioprine in Crohn's disease. Lancet. 1971 Oct 30;2(7731):944–947. doi: 10.1016/s0140-6736(71)90268-6. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES